Migraine Treatment Reyvow Discontinued, According to FDA
Headache and Pain Syndromes
-
Cluster Headache: A Distinct Approach to ManagementExperts discuss evidence-based strategies to improve the diagnosis and care of cluster headache. -
Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss DrugsA variety of research into GLP-1 RAs shows a pattern of adverse ocular effects, prompting recommendations for ophthalmic evaluations with their use. -
ACP Issues Clinical Guideline for Episodic Migraine With Pharmacologic TreatmentsThe American College of Physicians released new clinical guidance on the prevention of episodic migraine in adults who are not pregnant or lactating in an outpatient setting. -
Nurtec ODT for Patients With Migraines: Side Effects, Drug Interactions, and Cost SavingsWe've developed a comprehensive fact sheet on the side effects, drug interactions, and cost savings of Nurtec ODT for migraine for clinicians to share with their patients. -
Occipital Neuralgia vs Migraine: Comparing Diagnoses and TreatmentsWe've developed a comprehensive fact sheet for clinicians to share with patients and caregivers on the differences in diagnosis and treatment for occipital neuralgia vs migraine.
Clinical Tools
Powered by
Powered by 